Ourofino SA

Ourofino SA maintains a capital structure with a debt-to-equity ratio of 0.61, indicating a moderate level of leverage. The company's liquidity position is characterized by a current ratio of 3.55, suggesting strong short-term liquidity. However, the company has negative net cash after subtracting total debt, which is a key liquidity flag. In terms of profitability, Ourofino SA demonstrates a return on equity of 27.9% and a return on assets of 14.2%. These figures are strong indicators of the company's ability to generate returns from its equity and assets, respectively. The company's operating income of BRL 236.474 million and net income of BRL 222.311 million reflect its profitability in the veterinary industry. Ourofino SA's revenue is distributed across three segments: production animals, companion animals, and international operations. The production animals segment focuses on vaccines and veterinary products for ruminants, poultry, swine, and horses, while the companion animal segment deals with products for dogs and cats. The international operations segment serves markets such as Mexico and Colombia. The company's revenue concentration across these segments is not disclosed, but the international operations suggest a diversified geographic exposure. The company's growth trajectory is supported by its current revenue of BRL 1.225 billion. While specific growth projections for the next fiscal year are not provided, the company's strong operating cash flow of BRL 99.914 million and free cash flow of BRL 178.3 million indicate a solid financial foundation for future growth. Ourofino SA faces a medium liquidity risk, as indicated by its risk assessment. The company's dilution risk is low, with no significant dilution potential reported. The company's capital structure and financial performance suggest that it is not currently under pressure to issue additional shares, which supports the low dilution risk rating. Recent events and filings for Ourofino SA are not detailed in the provided data. However, the company's financial snapshot and valuation metrics provide a comprehensive view of its current financial health and operational performance.